Evidence for cross-species infections and cross-subtype mutations in influenza a matrix proteins

Viral Immunology

Volumn 23, Issue 1, 2010, Pages 105-111

  Yan, Shaomin ^a   Wu, Guang ^b  

^a Guangxi Academy of Sciences   (China)

^b DreamSciTech Consulting   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIX PROTEIN;

ANALYSIS OF VARIANCE; ARTICLE; CROSS INFECTION; DNA CROSS LINKING; INFLUENZA VIRUS A; NONHUMAN;

ANIMALS; BIRDS; GENETIC VARIATION; HORSE DISEASES; HORSES; HUMANS; INFLUENZA A VIRUS; INFLUENZA IN BIRDS; INFLUENZA, HUMAN; MUTATION, MISSENSE; ORTHOMYXOVIRIDAE INFECTIONS; SEQUENCE ANALYSIS, DNA; SWINE; SWINE DISEASES; VIRAL MATRIX PROTEINS;

AVES; INFLUENZA A VIRUS; SUIDAE;

EID: 76449106066     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2009.0080     Document Type: Article

References (57)

1. Althaus IW, Chou JJ, Gonzales AJ, et al.: Steady-state kinetic studies with the non-nucleoside HIV-1 reverse transcriptase inhibitor U-87201E. J Biol Chem 1993;268:6119-6124.
2. Barman S, Ali A, Hui EK, Adhikary L, and Nayak DP: Transport of viral proteins to the apical membranes and interaction of matrix protein with glycoproteins in the assembly of influenza viruses. Virus Res 2001;77:61-69.
3. Chou KC and Shen HB: Cell-PLoc: A package of web-servers for predicting subcellular localization of proteins in various organisms. Nature Prot 2008;3:153-162.
4. Chou KC and Shen HB: ProtIdent: A web server for identifying proteases and their types by fusing functional domain and sequential evolution information. Biochem Biophys Res Commun 2008;376:321-325.
5. Chou KC and Shen HB: Review: Recent progresses in protein subcellular location prediction.Analyt Biochem2007;370:1-16.
6. Chou KC and Shen HB: Signal-CF: a subsite-coupled and window-fusing approach for predicting signal peptides. Biochem Biophys Res Commun 2007;357:633-640.
7. Chou KC and Zhou GP: Role of the protein outside active site on the diffusion-controlled reaction of enzyme. J Am Chem Soc 1982;104:1409-1413.
8. Chou KC, Kezdy FJ, and Reusser F: Review: Steady-state inhibition kinetics of processive nucleic acid polymerases and nucleases. Analyt Biochem 1994;221:217-230.
9. Chou KC, Wei DQ, Du QS, Sirois S, and Zhong WZ: Review: Progress in computational approach to drug development against SARS. Curr Med Chem 2006;13:3263-3270.
10. Chou KC: A vectorized sequence-coupling model for predicting HIV protease cleavage sites in proteins. J Biol Chem 1993;268:16938-16948.
11. Chou KC: Energy-optimized structure of antifreeze protein and its binding mechanism. J Mol Biol 1992;223:509-517.
12. Chou KC: Graphical rules in steady and non-steady enzyme kinetics. J Biol Chem 1989;264:12074-12079.
13. Chou KC: Prediction of G-protein-coupled receptor classes. J Proteome Res 2005;4:1413-1418.
14. Chou KC: Review: Applications of graph theory to enzyme kinetics and protein folding kinetics. Steady and non-steady state systems. Biophys Chem 1990;35:1-24.
15. Chou KC: Review: Low-frequency collective motion in biomacromolecules and its biological functions. Biophys Chem 1988;30:3-48.
16. Chou KC: Review: Prediction of HIV protease cleavage sites in proteins. Analyt Biochem 1996;233:1-14.
17. Chou KC: Review: Structural bioinformatics and its impact to biomedical science. Curr Med Chem 2004;11:2105-2134.
18. Chou KC: The biological functions of low-frequency phonons: 6. A possible dynamic mechanism of allosteric transition in antibody molecules. Biopolymers 1987;26:285-295.
19. Du QS, Huang RB, and Chou KC: Review: Recent advances in QSAR and their applications in predicting the activities of chemical molecules, peptides and proteins for drug design. Curr Protein Pept Sci 2008;9:248-259.
20. Du QS, Huang RB, Wang CH, Li XM, and Chou KC: Energetic analysis of the two controversial drug binding sites of the M2 proton channel in influenza A virus. J Theoret Biol 2009;259:159-164.
21. Du QS, Wang SQ, and Chou KC: Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus. Biochem Biophys Res Commun 2007;362:525-531.
22. Furuse Y, Suzuki A, Kamigaki T, and Oshitani H: Evolution of the M gene of the influenza A virus in different host species: large-scale sequence analysis. Virology J 2009;6:67-79.
23. Gong K, Li L, Wang JF, Cheng F, Wei DQ, and Chou KC: Binding mechanism of H5N1 influenza virus neuraminidase with ligands and its implication for drug design. Med Chem 2009;5:242-249.
24. http:==www.ncbi.nlm.nih.gov=genomes=FLU=Database= multiple.cgi. 2009.
25. Huang RB, Du QS, Wang CH, and Chou KC: An in-depth analysis of the biological functional studies based on the NMR M2 channel structure of influenza A virus. Biochem Biophys Res Commun 2008;377:1243-1247.
26. Kida H, Ito T, Yasuda J, et al.: Potential for transmission of avian influenza viruses to pigs. J Gen Virol 1994;75:2183-2188.
27. Neumann G and Kawaoka Y: Host range restriction and pathogenicity in the context of influenza pandemic. Emerg Infect Dis 2006;12:881-886.
28. Pappaioanou M: Highly pathogenic H5N1 avian influenza virus: cause of the next pandemic? Comp Immunol Microbiol Infect Dis 2009;32:287-300.
29. Pielak RM, Jason R, Schnell JR, and Chou JJ: Mechanism of drug inhibition and drug resistance of influenza A M2 channel. Proc Natl Acad Sci USA 2009;106:7379-7384.
30. Poon LL, Leung YH, Nicholls JM, et al.: Vaccinia virus-based multivalent H5N1 avian influenza vaccines adjuvanted with IL-15 confer sterile cross-clade protection in mice. J Immunol 2009;182:3063-3071.
31. Prado-Prado FJ, Gonzalez-Diaz H, de la Vega OM, Ubeira FM, and Chou KC: Unified QSAR approach to antimicrobials. Part 3: First multi-tasking QSAR model for Input- Coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds. Bioorg Med Chem 2008;16:5871-5880.
32. Schnell JR and Chou JJ: Structure and mechanism of the M2 proton channel of influenza A virus. Nature 2008;451:591-595.
33. Shen HB and Chou KC: HIVcleave: a web-server for predicting HIV protease cleavage sites in proteins. Analyt Biochem 2008;375:388-390.
34. Shen HB and Chou KC: Identification of proteases and their types. Analyt Biochem 2009;385:153-160.
35. Shen HB and Chou KC: Signal-3L: a 3-layer approach for predicting signal peptide. Biochem Biophys Res Commun 2007;363:297-303.
36. Sirois S, Wei DQ, Du QS, and Chou KC: Virtual screening for SARS-CoV protease based on KZ7088 pharmacophore points. J Chem Inf Comput Sci 2004;44:1111-1122.
37. Sokal RR and Rohlf FJ: Biometry: The Principles and Practices of Statistics in Biological Research, 3rd ed. W.H. Freeman, New York, 1995, pp. 203-218.
38. SPSS Inc., SigmaStat for Windows Version 3.00, 1992-2003.
39. Wang JF, Wei DQ, and Chou KC: Insights from investigating the interactions of adamantane-based drugs with the M2 proton channel from the H1N1 swine virus. Biochem Biophys Res Commun 2009;388:413-417.
40. Wang SQ, Du QS, and Chou KC: Study of drug resistance of chicken influenza A virus (H5N1) from homology-modeled 3D structures of neuraminidases. Biochem Biophys Res Commun 2007;354:634-640.
41. Wang SQ, Du QS, Huang RB, Zhang DW, and Chou KC: Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus. Biochem Biophys Res Commun 2009;386:432-436.
42. Wei DQ, Du QS, Sun H, and Chou KC: Insights from modeling the 3D structure of H5N1 influenza virus neuraminidase and its binding interactions with ligands. Biochem Biophys Res Commun 2006;344:1048-1055.
43. Wei H, Wang CH, Du QS, Meng J, and Chou KC: Investigation into adamantane-based M2 inhibitors with FBQSAR. Med Chem 2009;5:305-317.
44. Wu G: Application of the queueing theory with Monte Carlo simulation to inhalation toxicology. Arch Toxicol 1998;72: 330-335.
45. Wu G: Application of queueing theory with Monte Carlo simulation to the study of the intake and adverse effects of ethanol. Alcohol Alcohol 1998;33:519-527.
46. Wu G and Yan S: Fate of influenza A virus proteins. Protein Pept Lett 2006;13:377-384.
47. Wu G and Yan S: Improvement of prediction of mutation positions in H5N1 hemagglutinins of influenza A virus using neural network with distinguishing of arginine, leucine and serine. Protein Pept Lett 2007;14:465-470.
48. Wu G and Yan S: Lecture Notes on Computational Mutation. Nova Science Publishers, New York, 2008.
49. Wu G and Yan S: Mutation trend of hemagglutinin of influenza A virus: a review from computational mutation viewpoint. Acta Pharmacol Sin 2006;27:513-526.
50. Wu G and Yan S: Prediction of mutations engineered by randomness in H5N1 hemagglutinins of influenza A virus. Amino Acids 2008;35:365-373.
51. Wu G and Yan S: Prediction of mutations in H1 neuraminidases from North America influenza A virus engineered by internal randomness. Mol Divers 2007;11:131-140.
52. Wu G and Yan S: Searching of main cause leading to severe influenza A virus mutations and consequently to influenza pandemics=epidemics. Am J Infect Dis 2005;1:116-123.
53. Wu G and Yan S: Timing of mutation in hemagglutinins from influenza A virus by means of unpredictable portion of amino-acid pair and fast Fourier transform. Biochem Biophys Res Commun 2005;333:70-78.
54. Wu G, Baraldo M, and Furlanut M: Inter-patient and intrapatient variations in the baseline tapping test in patients with Parkinson's disease. Acta Neurol Belg 1999;99:182-184.
55. Xiao X, Wang P, and Chou KC: GPCR-CA: A cellular automaton image approach for predicting G-protein-coupled receptor functional classes. J Comput Chem 2009;30:1414-1423.
56. Yu H, Zhang PC, Zhou YJ, et al.: Isolation and genetic characterization of avian-like H1N1 and novel ressortant H1N2 influenza viruses from pigs in China. Biochem Biophys Res Commun 2009;386:278-283.
57. Zhou GQ and Zhong WZ: Diffusion-controlled reactions of enzymes. A comparison between Chou's model and Alberty-Hammes-Eigen's model. Eur J Biochem 1982;128: 383-387.